1 Patients were eligible at first relapse or first designation
2 Patients were eligible for enrolment if they were aged 18 yea
3 Patients were eligible for inclusion as age-matched controls
4 Patients were eligible for inclusion if all of the following
5 Patients were eligible for inclusion if all of the following
6 Patients were eligible for inclusion if they had newly diagno
7 Patients were eligible for inclusion if they were aged 2 year
8 Patients were eligible for inclusion if they were aged 30 yea
9 Patients were eligible for participation if they had: metasta
10 Patients were eligible for the biliary tract cancer cohort if
11 Patients were eligible for the study if they were aged 18 yea
12 Patients were eligible for this matched, retrospective study
13 Patients were eligible for this randomised, double-blind, pla
14 Patients were eligible for up to eight infusions administered
15 Patients were eligible if 50 years or older, with type 2 diab
16 Patients were eligible if sufficient tumor characteristics we
17 Patients were eligible if they had a diagnosis of glaucoma fr
18 Patients were eligible if they had a Gly551Asp-CFTR mutation
19 Patients were eligible if they had an advanced, histologicall
20 Patients were eligible if they had an ankle-brachial index (A
21 Patients were eligible if they had an ECOG performance status
22 Patients were eligible if they had chronic lymphocytic leukae
23 Patients were eligible if they had completed the phase 3 APOL
24 Patients were eligible if they had disease progression after
25 Patients were eligible if they had received one or two previo
26 Patients were eligible if they had symptomatic thrombosis (at
27 Patients were eligible if they received combination therapy f
28 Patients were eligible if they were adults with HIV, who were
29 Patients were eligible if they were age 18 to 70 years with p
30 Patients were eligible if they were aged 0-17 years with 3 or
31 Patients were eligible if they were aged 16 years or older, a
32 Patients were eligible if they were aged 16 years or older; m
33 Patients were eligible if they were aged 18 years or more and
34 Patients were eligible if they were aged 18 years or older (1
35 Patients were eligible if they were aged 18 years or older an
36 Patients were eligible if they were aged 18 years or older, H
37 Patients were eligible if they were aged 21 years or older, i
38 Patients were eligible if they were aged 21-70 years, diagnos
39 Patients were eligible if they were aged 50 years or older, h
40 Patients were eligible if they were at least 12 years old wit
41 Patients were eligible if they were at least aged 18 years, h
42 Patients were eligible if they were older than 16 years, had
43 Patients were eligible if they were older than 18 years, able
44 Patients were eligible if they were older than 18 years, had
45 Patients were eligible if they were: >/=18 years old; at risk
46 Patients were eligible regardless of ejection fraction, and w
47 Patients were eligible to be enrolled if they had nonvalvular
48 Patients were eligible to be included in the study if they we
49 Patients were eligible to participate if they were aged 20-60
50 Patients were eligible to receive an initial induction cycle